Alcohol-induced acute pancreatitis

ALCOPANCACU

alcoholic pancreatitis: Acute or chronic inflammation of the pancreas due to excessive alcohol drinking. Alcoholic pancreatitis usually presents as an acute episode but it is a chronic progressive disease in alcoholics.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K85.2 Hospital discharge: ICD-9 — 5770D\|5770E Cause of death: ICD-10 — K85.2 Cause of death: ICD-9 — 5770D\|5770E 2 out of 7 registries used, show all original rules.	1312
4. Check minimum number of events None	1312
5. Include endpoints None	1312
6. Filter based on genotype QC (FinnGen only)	1312

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K85

NAME	ALCOPANCACU
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K852
HD_ICD_9	5770D\|5770E
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K852
COD_ICD_9	5770D\|5770E
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Alcohol-induced acute pancreatitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	13938	2274	11487
Only index persons	9836	1787	8049
Unadjusted period prevalence (%)
Whole population	0.28	0.07	0.32
Only index persons	0.26	0.07	0.31
Median age at first event (years)
Whole population	45.74	48.04	45.21
Only index persons	46.50	48.71	46.01

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1312	242	1070
Unadjusted period prevalence (%)	0.40	0.08	0.47
Median age at first event (years)	48.87	48.67	48.91

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1168: Matched controls
11680

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

5770D

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA NONHAEMORHAGICA]

+∞

323.0

445

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

120.6

323.0

462

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

16384.0

323.0

711

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

59.3

319.7

374

K85

ICD-10 Finland

Acute pancreatitis

38.7

190.8

244

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

10.9

190.4

408

550

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

135.8

183.6

193

JN3AD

NOMESCO Finland

Abdominal CT examination

10.5

164.7

353

461

K86.1

ICD-10 Finland

Other chronic pancreatitis

66.4

160.8

185

JN3BD

NOMESCO Finland

Extensive abdominal CT

8.4

157.9

397

675

A09AA02

ATC

multienzymes (lipase, protease etc.)

26.9

142.3

200

K86.3

ICD-10 Finland

Pseudocyst of pancreas

102.7

140.0

152

K85.0

ICD-10 Finland

Idiopathic acute pancreatitis

93.4

133.8

147

R10.1

ICD-10 Finland

Pain localized to upper abdomen

6.3

123.2

383

839

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

30.1

122.2

166

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

4.1

106.0

596

2371

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

5.5

104.9

364

887

P15

ICPC

Chronic alcohol abuse

12.1

103.9

199

195

N07BB01

ATC

disulfiram; oral

8.1

100.0

245

372

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

6.8

99.8

279

514

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

12.4

95.6

180

169

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

27.5

93.6

130

K86.01

ICD-10 Finland

Late effects of pancreatitis caused by alcohol

150.9

92.6

5770F

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA RECIDIVANS]

335.2

92.2

F10.25

ICD-10 Finland

Alcohol dependence continuous use

14.9

87.7

151

115

N02AX02

ATC

tramadol; systemic, rectal

3.4

84.0

702

3607

JLW98

NOMESCO Finland

Other transluminal endoscopic operation on pancreas

205.8

75.1

F10.20

ICD-10 Finland

Alcohol dependence currently independent

11.2

73.0

143

A10AE04

ATC

insulin glargine; parenteral

4.9

72.8

268

665

N05CF01

ATC

zopiclone; oral

3.2

70.8

506

2224

103

Kela drug reimbursment

Diabetes, insulin-treated

3.2

69.8

495

2160

N05BA01

ATC

diazepam; systemic, rectal

4.3

69.7

298

857

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

5.4

69.0

229

504

N06AX11

ATC

mirtazapine; oral

3.2

68.6

508

2278

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

12.3

68.4

128

116

N05AH04

ATC

quetiapine; oral

3.9

67.9

328

1052

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

15.7

67.6

113

F10.24

ICD-10 Finland

Alcohol depence active use

13.7

65.0

115

K85.8

ICD-10 Finland

Other acute pancreatitis

29.9

60.1

F10.09

ICD-10 Finland

Alcohol intoxication UNS

10.4

59.7

121

128

TPH04

NOMESCO Finland

Cathetrisation of vein

3.3

57.8

370

1457

A02BC02

ATC

pantoprazole; systemic

2.8

57.0

847

5643

N05BA04

ATC

oxazepam; oral

3.2

56.2

368

1467

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.0

56.0

436

1955

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.9

53.7

435

1988

P16

ICPC

Acute alcohol abuse

11.5

52.8

101

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.3

51.4

313

1172

5770E

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICAHAEMORRHAGICA]

+∞

50.4

R10.0

ICD-10 Finland

Acute abdomen

9.7

49.7

104

116

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

9.8

49.5

103

114

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

12.1

49.3

N05BA02

ATC

chlordiazepoxide; systemic

7.8

48.5

116

162

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

7.3

48.3

121

181

N06AB04

ATC

citalopram; systemic

3.0

47.9

336

1380

K86.9

ICD-10 Finland

Disease of pancreas, unspecified

35.7

47.4

XF400

NOMESCO Finland

ECG with 12 standard connections

3.2

46.7

297

1136

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

13.1

44.8

R56.8

ICD-10 Finland

Other and unspecified convulsions

5.4

44.7

143

294

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

26.7

44.1

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.7

43.9

217

683

K92.0

ICD-10 Finland

Haematemesis

8.6

43.7

123

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.4

43.2

606

3644

N05CD07

ATC

temazepam; oral

3.6

43.1

222

721

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.7

43.1

130

249

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

10.6

42.3

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

10.3

42.3

T90

ICPC

Diabetes non-insulin dependent

2.7

42.1

376

1768

K70.1

ICD-10 Finland

Alcoholic hepatitis

17.7

40.6

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.6

40.3

367

1739

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

5.5

39.7

123

243

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.5

38.6

396

1994

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

12.3

38.2

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

9.2

37.8

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

13.6

37.8

Z72.1

ICD-10 Finland

Alcohol use

10.5

37.7

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

12.4

37.2

UJK02

NOMESCO Finland

ERCP

8.2

35.9

106

TKC20

NOMESCO Finland

Catheterisation of bladder

4.1

35.8

152

415

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.9

35.0

239

938

K86.8

ICD-10 Finland

Other specified diseases of pancreas

127.2

34.9

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

19.1

34.7

K29.2

ICD-10 Finland

Alcoholic gastritis

40.5

34.5

N05AB01

ATC

dixyrazine; systemic

10.0

34.4

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

6.6

33.3

145

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

6.0

33.1

170

WX892

NOMESCO Finland

Monitored bed care

3.7

32.2

153

459

C07AA05

ATC

propranolol; systemic

2.7

32.0

261

1136

D02

ICPC

Abdominal pain epigastric

5.0

31.4

106

230

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.6

31.3

260

1144

N06AB10

ATC

escitalopram; oral

2.6

31.1

266

1187

R4110

NOMESCO Finland

Physiotherapy

2.3

30.2

355

1867

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

11.0

30.2

T89

ICPC

Diabetes insulin dependent

5.2

30.1

204

N03AX16

ATC

pregabalin; oral

2.3

29.7

323

1635

N06AX16

ATC

venlafaxine; oral

2.9

29.5

206

814

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.4

29.0

154

504

A06AD11

ATC

lactulose; oral

2.9

28.7

198

773

V03AA01

ATC

5.8

28.6

151

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

3.5

28.4

141

437

A02BA02

ATC

ranitidine; systemic

2.5

27.9

266

1254

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

43.7

27.8

JLD12

NOMESCO Finland

Endoscopic drainage of pancreatic pseudocyst

102.6

27.8

A10BA02

ATC

metformin; oral

2.1

27.7

392

2231

E13

ICD-10 Finland

Other specified diabetes mellitus

26.1

27.6

K85.1

ICD-10 Finland

Biliary acute pancreatitis

21.7

27.5

SPAT1265

SPAT

Breathalyser

10.4

27.4

TPH07

NOMESCO Finland

Cathetrisation of artery

3.0

27.4

173

638

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

16.3

27.4

E13.7

ICD-10 Finland

Other specified diabetes mellitus, with multiple complications

277.1

26.8

5770A

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA NONHAEMORRHAGICA]

46.9

26.6

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

5.9

26.4

137

I10

ICD-10 Finland

Essential (primary) hypertension

1.9

26.4

684

4913

JLB28

NOMESCO Finland

Endoscopic internal drainage of pancreatic duct

74.4

25.9

D01

ICPC

Abdominal pain/cramps general

3.3

25.7

139

460

N02BE01

ATC

paracetamol; systemic, rectal

2.3

25.6

989

8267

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.9

25.3

165

619

N06AB03

ATC

fluoxetine; oral

2.8

24.9

180

719

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

24.6

307

1636

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

4.5

24.1

207

N06AA12

ATC

doxepin; systemic

4.1

24.1

261

AA1AD

NOMESCO Finland

CT of head and brain

2.2

24.1

308

1656

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

6.9

24.0

K86.0

ICD-10 Finland

Alcohol-induced chronic pancreatitis

68.9

23.9

J01DB01

ATC

cefalexin; oral

2.1

23.7

955

7927

JLC50

NOMESCO Finland

Atypical pancreatectomy

127.6

23.7

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

8.2

23.6

N05CF02

ATC

zolpidem; oral

2.4

23.4

230

1090

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

6.4

23.3

101

K92.1

ICD-10 Finland

Melaena

3.9

23.3

269

K70.0

ICD-10 Finland

Alcoholic fatty liver

12.8

23.2

R11

ICD-10 Finland

Nausea and vomiting

3.7

23.2

105

301

5772A

ICD-9 Finland

Diseases of pancreas, Cyst and pseudocyst of pancreas[CYSTA ET PSEUDOCYSTA PANCREATIS]

55.2

23.1

C03CA01

ATC

furosemide; systemic

2.1

22.8

312

1724

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

22.3

349

2033

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

11.8

21.8

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

10.1

21.7

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

3.5

21.6

106

325

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

7.7

21.5

5353A

ICD-9 Finland

Gastritis and duodenitis, Alcoholic gastritis

51.0

21.2

A02BC05

ATC

esomeprazole; systemic

1.9

21.1

472

3121

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

19.9

20.9

WX002

NOMESCO Finland

Sedation and analgesia

2.2

20.4

250

1305

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

20.4

562

3975

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.6

20.4

155

638

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.8

20.2

244

A02BC01

ATC

omeprazole; systemic

2.0

20.2

330

1942

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.2

20.1

112

376

EBA00

NOMESCO Finland

Extraction of tooth

1.9

20.0

412

2638

N17.9

ICD-10 Finland

Acute renal failure, unspecified

4.3

19.8

188

A03DA02

ATC

pitofenone and analgesics; systemic

9.6

19.7

D64.9

ICD-10 Finland

Anaemia, unspecified

2.8

19.6

137

534

JLB35

NOMESCO Finland

Transduodenal endoscopic extraction of foreign body from pancreatic duct

106.8

19.6

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

7.1

19.6

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.3

19.6

105

344

N05BE01

ATC

buspirone; oral

4.7

19.3

150

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

15.1

19.0

S01.0

ICD-10 Finland

Open wound of scalp

2.8

18.8

132

515

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

7.6

18.8

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

13.7

18.8

5771C

ICD-9 Finland

Diseases of pancreas, Chronic pancreatitis[PANCREATITIS CHRONICA ALCOHOLICA RECIDIVANS]

101.7

18.6

S06.0

ICD-10 Finland

Concussion

2.6

18.5

144

599

X59

ICD-10 Finland

Exposure to unspecified factor

2.1

18.5

250

1358

SPAT1262

SPAT

Handing over of treatment supplies

2.1

18.5

248

1342

F51.0

ICD-10 Finland

Nonorganic insomnia

2.5

18.4

160

707

N05AA02

ATC

levomepromazine; systemic

3.4

18.3

276

C08CA01

ATC

amlodipine; oral

1.8

18.3

411

2687

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

8.5

18.0

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.4

18.0

285

SPAT1227

SPAT

Substance abuse rehabilitation

10.9

18.0

W19

ICD-10 Finland

Unspecified fall

2.6

17.7

136

561

5770C

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA RECIDIVANS]

182.6

17.6

P01AB01

ATC

metronidazole; oral, rectal

1.8

17.5

407

2683

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

6.8

17.5

K86.2

ICD-10 Finland

Cyst of pancreas

13.4

17.5

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

29.3

17.5

N05BA12

ATC

alprazolam; oral

2.5

17.4

143

611

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

8.0

17.4

UJD02

NOMESCO Finland

Gastroscopy

3.8

17.4

207

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

8.3

17.3

N03AX12

ATC

gabapentin; oral

2.2

17.0

189

941

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

7.4

16.9

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

7.4

16.9

J01MA12

ATC

levofloxacin; systemic

2.0

16.8

243

1352

SPAT1254

SPAT

Administration of medicine

2.3

16.7

162

756

N06AB06

ATC

sertraline; oral

2.5

16.5

136

583

N02AA05

ATC

oxycodone; systemic

2.2

16.5

175

851

N07BA03

ATC

varenicline; oral

3.0

16.5

343

57709

ICD-8 Finland

Diseases of pancreas, Pancreatitis NUD

23.4

16.5

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

5.4

16.3

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

11.4

16.3

N05AH03

ATC

olanzapine; systemic

3.1

16.3

325

A10AE05

ATC

insulin detemir; parenteral

3.0

16.3

331

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

15.6

16.2

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.2

16.2

154

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

4.7

15.9

119

A10AE06

ATC

insulin degludec; parenteral

4.2

15.9

152

N06AX03

ATC

mianserin; oral

3.5

15.8

219

JAH33

NOMESCO Finland

Opening of laparostomy

33.9

15.8

F41.09

ICD-10 Finland

UNS Panic Syndrome

5.3

15.7

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

4.6

15.7

125

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

15.7

204

1084

S22.3

ICD-10 Finland

Fracture of rib

2.6

15.6

115

463

N06AA09

ATC

amitriptyline; systemic

2.5

15.6

126

532

Z71.8

ICD-10 Finland

Other specified counselling

1.9

15.3

243

1394

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.1

15.3

148

WX882

NOMESCO Finland

High dependency care

4.4

15.3

129

WX730

NOMESCO Finland

Conventional respirator

6.2

15.1

P01

ICPC

Feeling anxious/nervous/tense

2.8

15.1

101

385

E87.6

ICD-10 Finland

Hypokalaemia

4.4

15.0

131

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.1

14.9

182

940

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

32.1

14.8

D10

ICPC

Vomiting

3.6

14.7

194

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

14.6

453

3209

SPAT1247

SPAT

Outpatient detoxication and monitoring

11.0

14.5

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.4

14.5

218

N03AF01

ATC

carbamazepine; oral, rectal

3.2

14.5

257

5770B

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA HAEMORRHAGICA]

151.8

14.5

WYA20

NOMESCO Finland

Home visit

7.7

14.5

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

14.3

223

1266

A41.9

ICD-10 Finland

Sepsis, unspecified

3.6

14.3

183

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

8.8

14.3

WX872

NOMESCO Finland

Intensive care

2.8

14.3

342

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

9.3

14.2

P76

ICPC

Depressive disorder

3.2

14.2

255

B01AB05

ATC

enoxaparin; parenteral

1.8

14.1

327

2121

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.5

14.1

114

482

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

5.3

14.0

K70.4

ICD-10 Finland

Alcoholic hepatic failure

10.2

14.0

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

13.9

187

1001

A10BH01

ATC

sitagliptin; oral

2.3

13.9

134

620

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.3

13.9

226

E86

ICD-10 Finland

Volume depletion

5.0

13.8

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

13.5

430

3053

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

13.0

13.4

JAH00

NOMESCO Finland

Laparotomy

4.3

13.3

118

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.7

13.3

352

S18

ICPC

Laceration/cut

1.6

13.2

458

3321

N06AX05

ATC

trazodone; oral

4.6

13.1

101

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

3.5

13.1

181

M54.5

ICD-10 Finland

Low back pain

1.7

13.1

348

2346

WX110

NOMESCO Finland

Local anesthesy

1.6

13.0

754

6216

F32

ICD-10 Finland

Depressive episode

3.3

13.0

209

P03

ICPC

Feeling depressed

2.7

13.0

369

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.7

13.0

161

R53

ICD-10 Finland

Malaise and fatigue

1.9

12.9

207

1185

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.3

12.8

122

561

K05.31

ICD-10 Finland

Periodontitis pronounced

2.2

12.8

145

722

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.2

12.7

213

J01DA01

ATC

[U] cefalexin; systemic

1.6

12.6

670

5386

WX402

NOMESCO Finland

General anaesthesia

1.9

12.5

195

1103

JLT00

NOMESCO Finland

Extracorporeal shock wave lithotripsy of pancreatic duct

+∞

12.5

E13.3

ICD-10 Finland

Other specified diabetes mellitus, with ophthalmic complications

+∞

12.5

N06AX21

ATC

duloxetine; oral

2.3

12.5

125

589

A01

ICPC

Pain general/multiple sites

2.7

12.5

327

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.4

12.4

112

501

T74.1

ICD-10 Finland

Physical abuse

5.7

12.4

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

12.4

268

1697

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

6.3

12.3

P18

ICPC

Medication abuse

9.8

12.3

A02BC03

ATC

lansoprazole; oral

1.7

12.2

313

2080

X57

ICD-10 Finland

Unspecified privation

4.3

12.2

109

K83.1

ICD-10 Finland

Obstruction of bile duct

6.5

12.2

XF600

NOMESCO Finland

Bloodpressure measurement

2.7

12.2

336

TK800

NOMESCO Finland

Hemodialysis

3.9

12.1

129

A10BB12

ATC

glimepiride; oral

2.5

12.1

410

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.5

12.1

171

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

3.5

12.1

171

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3000570) Elastase.pancreatic [Mass/mass] in Stool

264

308

10.48

215.55

1.8

1.4

ug/g

163.2

271.2

9.96

160

181

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

472

1259

5.29

171.75

5.5

3.0

umol/l

10.0

9.0

0.37

416

1130

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

416

998

5.64

171.17

9.1

2.5

u/l

86.4

87.6

0.01

371

878

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

794

3337

4.49

157.19

7.5

2.7

u/l

100.8

57.7

9.96

750

3123

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

982

5533

4.08

112.83

14.0

6.7

umol/l

13.3

12.2

0.98

943

5281

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

473

1710

3.76

107.95

3.3

2.0

1.9

1.5

9.76

404

1511

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

348

1058

4.12

101.35

3.7

2.3

g/l

0.2

6.94

328

982

(3023368) Bacteria identified in Blood by Culture

650

3042

3.25

95.62

6.9

4.5

—

(3033658) Prothrombin time (PT) actual/Normal

609

2762

3.25

94.20

9.4

4.2

86.6

88.6

1.27

592

2709

(3023183) Ammonium ion [Moles/volume] in Plasma

171

306

6.28

93.49

4.2

3.0

umol/l

38.3

37.3

0.10

151

262

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

703

3581

3.07

86.87

5.7

3.5

u/l

58.6

40.2

0.68

665

3389

(3024561) Albumin [Mass/volume] in Serum or Plasma

801

4468

3.04

82.57

9.3

5.3

g/l

32.7

35.7

27.53

755

4194

(3003458) Phosphate [Moles/volume] in Serum or Plasma

371

1422

3.24

73.41

7.6

7.1

mmol/l

1.0

0.40

351

1334

(3014111) Lactate [Moles/volume] in Serum or Plasma

297

1001

3.54

72.23

11.7

8.7

mmol/l

1.6

1.4

1.69

287

970

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

782

4546

2.78

70.37

11.3

6.8

mmol/l

1.2

9.81

736

4136

(3012095) Magnesium [Moles/volume] in Serum or Plasma

422

1782

3.02

70.15

4.7

3.8

mmol/l

0.8

20.47

400

1687

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

193

512

4.25

65.95

5.6

4.3

mmol/l

23.6

24.2

1.14

176

465

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

131

258

5.53

64.16

1.3

1.8

nmol/l

0.6

0.9

3.14

105

228

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

814

4986

2.67

63.38

11.8

7.4

mmol/l

1.2

7.86

702

4237

(3013826) Glucose [Moles/volume] in Serum or Plasma

954

6336

2.85

62.90

10.6

5.3

mmol/l

7.7

6.8

17.42

921

5993

(3000991) Gas panel - Venous blood

273

946

3.38

62.87

14.1

10.3

—

(3018418) pH of Serum or Plasma

557

2904

2.60

59.73

5.5

4.5

7.4

0.12

569

(3020779) Urea [Moles/volume] in Serum or Plasma

287

1062

3.18

59.00

8.2

8.8

mmol/l

9.0

9.7

0.93

273

1018

(3032080) INR in Blood by Coagulation assay

742

4464

2.52

58.11

9.9

9.2

inr

1.2

1.3

2.96

192

1263

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

122

7.29

55.59

1.4

1.2

nmol/l

0.8

1.5

6.38

110

(3044640) Blood type and Crossmatch panel - Blood

586

3232

2.47

54.48

4.2

2.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

101

182

5.93

54.24

1.4

1.7

g/l

0.7

0.9

0.61

140

(3020191) Ethanol [Moles/volume] in Serum or Plasma

100

7.78

52.14

2.3

1.5

promille

2.2

1.2

3.87

(3012544) pH of Venous blood

270

1031

3.04

52.05

5.7

4.0

—

7.4

—

(3009508) Creatinine [Moles/volume] in Urine

616

3550

2.39

50.99

4.2

3.3

mmol/l

7.1

8.6

12.06

513

2999

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

482

2506

2.46

50.12

3.8

2.5

—

(3002032) Base excess in Venous blood by calculation

261

1002

3.00

49.66

5.7

3.9

mmol/l

1.2

2.0

1.85

219

788

(3002582) Erythrocytes [#/volume] in Urine

571

3222

2.37

49.13

3.9

3.3

e6/l

33.9

93.9

1.76

454

2498

(3021447) Carbon dioxide [Partial pressure] in Venous blood

259

1002

2.97

48.52

5.8

3.9

kpa

5.7

5.9

1.42

251

970

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

187

600

3.47

47.93

15.0

12.4

mmol/l

23.4

24.4

2.82

179

574

(3030467) Casts [#/volume] in Urine by Automated count

532

2942

2.36

47.60

3.9

3.2

e6/l

0.6

0.5

0.57

419

2223

(36304419) Bacteria [Presence] in Urine

521

2873

2.35

46.73

3.9

3.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

457

2392

2.40

46.08

2.5

2.1

mg/l

2.8

3.0

0.51

387

2046

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1075

8138

2.78

45.53

16.0

7.9

u/l

91.4

78.1

14.80

1037

7714

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

10.36

45.35

2.7

1.9

umol/l

119.3

125.1

0.05

(3000850) Epithelial cells [#/volume] in Urine

427

2189

2.41

44.93

3.0

2.6

e6/l

5.5

3.9

1.38

380

1926

(3026782) Osmolality of Urine

405

2029

2.44

44.84

3.1

2.8

mosm/kgh2o

487.3

582.1

13.91

350

1731

(3018095) Leukocytes [#/volume] in Urine

608

3639

2.25

44.22

4.4

3.7

e6/l

53.4

94.3

0.66

469

2667

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

633

3862

2.23

43.79

4.0

3.3

—

(3012516) Albumin [Mass/volume] in Urine

564

3351

2.20

40.92

4.0

3.3

mg/l

408.5

251.6

0.38

379

2300

(3028707) Methadone [Presence] in Urine by Screen method

167

5.24

39.43

4.1

3.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

885

6345

2.21

38.82

5.1

3.9

e6/l

1154.7

921.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

577

3523

2.14

38.39

5.0

4.1

mg/mmol

20.2

8.9

2.74

380

2383

(40758558) Short blood count panel - Blood

459

2570

2.21

38.04

7.1

7.0

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

292

1347

2.50

37.94

14.5

8.6

kpa

4.9

5.2

2.80

279

1297

(3003396) Base excess in Arterial blood by calculation

291

1341

2.50

37.89

14.6

8.6

mmol/l

0.0

1.1

2.50

242

1061

(3027801) Oxygen [Partial pressure] in Arterial blood

292

1348

2.50

37.87

14.5

8.6

kpa

11.1

12.1

4.12

279

1301

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

394

2079

2.28

37.70

5.1

3.7

ng/l

76.9

525.3

7.19

322

1647

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

633

4034

2.10

37.29

2.4

1.9

pmol/l

87.2

94.0

3.38

362

2257

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

7.84

35.85

1.3

mmol/l

12.2

12.6

0.12

(3015377) Calcium [Moles/volume] in Serum or Plasma

533

3228

2.10

35.52

3.7

3.4

mmol/l

2.3

4.84

471

2860

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

338

1709

2.32

35.49

3.1

3.0

e6/l

1.7

0.9

0.97

179

953

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

336

1701

2.31

35.13

2.0

1.9

—

(3042936) Bacteria identified in Isolate by Culture

325

1623

2.33

35.08

3.1

2.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

350

1826

2.25

33.90

3.1

2.8

e6/l

0.7

0.9

1.16

193

1065

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

132

422

3.37

33.66

2.6

2.5

ug/l

387.5

494.1

0.33

126

400

(3016502) Oxygen saturation in Arterial blood

266

1242

2.43

33.27

15.6

8.8

95.2

95.7

0.71

258

1199

(3024354) Oxygen [Partial pressure] in Venous blood

202

827

2.71

33.23

4.2

3.0

kpa

4.9

4.6

0.80

193

799

(3011288) Drugs identified in Urine by Screen method

232

4.19

33.12

4.2

3.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

184

4.57

32.41

1.1

iu/ml

5.0

34.3

1.16

(3051651) Icteric interference index of Serum or Plasma

7.29

32.36

4.9

3.9

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

701

4810

1.98

31.87

5.8

4.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

826

6041

1.99

30.73

8.8

9.5

e9/l

5.2

4.2

16.10

731

5282

(3019309) Folate [Moles/volume] in Red Blood Cells

330

1750

2.18

30.26

2.0

1.7

nmol/l

1143.8

1164.8

0.14

252

1361

(3003181) Sodium [Moles/volume] in Urine

154

4.75

29.93

1.5

1.3

mmol/l

57.6

62.4

0.29

130

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

229

1046

2.44

29.82

3.2

4.6

ug/l

5.4

27.0

1.85

196

872

(3002173) Hemoglobin [Mass/volume] in Arterial blood

245

1154

2.38

29.79

16.4

9.3

g/l

117.5

124.9

5.25

239

1108

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

126

422

3.20

29.71

2.9

3.9

u/ml

155.4

3417.2

0.77

111

363

(44816559) Phosphatidylethanol [Mass/volume] in Blood

243

3.90

29.49

2.5

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

5.83

28.81

5.0

3.7

—

(42870588) Differential panel, method unspecified - Blood

548

3574

1.92

27.78

5.1

6.2

—

(3024928) Oxygen saturation in Venous blood

247

3.75

27.27

3.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

284

3.53

26.81

3.7

2.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

173

727

2.59

26.74

1.6

—

(40768797) Stomach Pathology biopsy report

270

1382

2.20

26.71

1.4

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

6.75

26.49

1.4

1.5

nmol/l

0.8

1.2

1.49

(3027135) IgG subclass 1 [Mass/volume] in Serum

106

5.27

26.33

1.3

g/l

6.0

6.8

0.87

(3028192) IgG subclass 2 [Mass/volume] in Serum

106

5.27

26.33

1.3

g/l

3.4

3.0

0.45

(3024139) IgG subclass 3 [Mass/volume] in Serum

106

5.27

26.33

1.3

g/l

0.4

0.54

(4062490)

107

5.22

26.06

1.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

967

7673

1.99

25.97

8.4

3.2

u/l

123.2

57.0

15.09

911

7234

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

501

3233

1.89

25.75

3.0

2.2

u/l

285.6

286.6

0.01

474

3057

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

155

630

2.66

25.59

1.8

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

249

1262

2.20

25.11

2.0

1.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

112

386

3.08

25.09

2.9

2.7

u/ml

0.3

0.64

215

(3017143) Hepatitis C virus Ab [Presence] in Serum

245

1237

2.21

24.93

1.8

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

238

1188

2.23

24.91

1.9

1.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

380

2258

1.96

24.90

1.8

1.5

nmol/l

21.2

19.9

0.88

339

1947

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

160

673

2.57

24.61

17.2

11.6

—

(3052851) Hemolysis interference index of Serum or Plasma

300

3.34

24.60

6.4

3.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

271

1432

2.12

24.53

3.1

2.7

25.8

24.2

0.68

233

1237

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

239

1204

2.20

24.42

1.9

1.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

313

3.27

24.25

1.2

titre

87.7

94.0

0.08

(3027945) Reticulocytes/100 erythrocytes in Blood

236

1186

2.21

24.24

2.0

2.6

1.9

1.8

1.14

201

1065

(3004789) Transferrin [Mass/volume] in Serum or Plasma

280

1511

2.08

23.92

3.1

2.6

g/l

2.1

2.3

4.46

255

1413

(3016879) Cocaine [Presence] in Urine

102

346

3.11

23.46

3.7

2.5

—

(3006504) Eosinophils/100 leukocytes in Blood

675

4901

1.78

22.67

5.4

6.4

2.7

2.9

1.83

631

4604

(3022948) Iron [Moles/volume] in Serum or Plasma

291

1622

2.02

22.62

3.0

2.6

umol/l

11.9

13.8

4.05

267

1522

(3019069) Monocytes/100 leukocytes in Blood

677

4926

1.77

22.51

5.6

6.7

8.9

9.0

0.25

638

4641

(3022096) Basophils/100 leukocytes in Blood

659

4779

1.76

21.98

5.4

6.4

0.6

0.7

0.78

620

4497

(3005719) IgG [Mass/volume] in Serum or Plasma

180

848

2.30

21.46

2.1

2.4

g/l

10.9

10.6

0.29

146

785

(3000764) Benzodiazepines [Presence] in Urine

102

368

2.92

21.04

3.7

2.4

—

(3018010) Neutrophils/100 leukocytes in Blood

674

4962

1.74

20.94

5.4

6.3

60.0

57.3

7.52

634

4681

(3002030) Lymphocytes/100 leukocytes in Blood

681

5035

1.73

20.78

5.6

6.5

24.3

27.5

12.28

636

4726

(3033799) Differential panel - Peritoneal fluid

8.33

20.56

1.3

2.1

—

(3028300) Cannabinoids [Presence] in Urine

102

375

2.86

20.33

3.8

2.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

561

3948

1.74

20.30

3.4

2.7

ug/l

213.4

175.7

1.44

501

3658

(3022217) INR in Platelet poor plasma by Coagulation assay

250

1368

2.02

20.26

15.7

23.0

inr

1.1

1.3

2.65

186

(3018677) aPTT in Platelet poor plasma by Coagulation assay

298

1735

1.93

20.18

2.3

2.2

30.5

29.9

0.93

291

1686

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

242

1312

2.04

20.11

1.7

1.6

—

(4198724)

6.24

19.44

2.3

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

296

1739

1.91

19.42

3.5

3.2

mmol/l

2.5

2.4

1.56

250

1535

(3027008) Opiates [Presence] in Urine

100

374

2.81

19.30

3.8

2.4

—

(3027944) Amphetamines [Presence] in Urine

369

2.79

18.68

3.9

2.3

—

(1616796) Gas panel - Central venous blood

257

3.12

18.19

4.0

4.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

118

495

2.52

18.13

1.7

1.8

g/l

1.7

1.6

1.03

101

423

(3026008) Bacteria identified in Urine by Culture

359

2292

1.78

17.81

3.1

2.9

—

(3006315) Basophils [#/volume] in Blood

689

5260

1.65

17.43

5.4

6.1

e9/l

0.0

1.71

590

4557

(3037467) Urinalysis macro (dipstick) panel - Urine

859

6942

1.69

17.39

4.9

3.9

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

137

628

2.32

17.30

1.6

1.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

529

3783

1.67

17.23

2.6

2.2

nmol/l

66.2

74.3

7.43

467

3415

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

222

1231

1.97

17.11

2.8

4.4

u/l

213.2

240.0

4.89

204

1174

(3019198) Lymphocytes [#/volume] in Blood

698

5374

1.64

16.85

5.5

6.2

e9/l

1.8

2.0

1.67

600

4748

(3023520) Reticulocytes [#/volume] in Blood

174

890

2.10

16.75

2.3

2.7

e9/l

69.6

71.1

0.20

118

689

(3013115) Eosinophils [#/volume] in Blood

703

5429

1.64

16.71

5.9

6.4

e9/l

0.2

0.51

605

4786

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

139

652

2.27

16.62

5.5

4.5

ng/l

106.9

93.7

0.89

123

582

(3001604) Monocytes [#/volume] in Blood

683

5242

1.63

16.60

5.4

6.1

e9/l

0.7

0.6

8.74

584

4535

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

566

4149

1.64

16.53

5.2

3.6

ng/l

49.2

52.5

0.05

434

2945

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

4.49

15.97

1.5

1.6

—

(3012501) Base excess in Blood by calculation

246

2.95

15.14

6.0

5.5

mmol/l

2.4

0.03

167

(3010421) pH of Blood

299

2.75

14.91

5.7

5.1

7.4

0.08

243

(1761868) Lipid panel - Serum or Plasma

292

4292

0.59

13.96

3.1

2.8

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

4.79

13.81

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

4.79

13.81

1.1

1.0

—

(3007164) IgA [Mass/volume] in Serum or Plasma

288

1841

1.72

13.77

1.6

1.4

g/l

3.7

2.6

5.84

160

1200

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

235

2.86

13.38

2.3

3.9

u/ml

40.4

267.0

1.32

221

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

302

1971

1.69

13.33

1.3

1.2

u/ml

2.7

1.7

0.49

561

(3004588) Protein electrophoresis panel - Serum or Plasma

134

678

2.09

13.19

2.2

2.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

4.58

13.11

1.0

1.1

—

(3009343) pH of Capillary blood

142

740

2.03

12.91

3.9

3.4

7.4

0.03

(3011397) Hemoglobin [Presence] in Urine by Test strip

335

2264

1.64

12.87

3.5

3.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

193

1118

1.85

12.82

6.2

3.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

143

750

2.02

12.77

3.9

3.4

kpa

5.0

5.2

1.18

133

696

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

192

3.00

12.68

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

214

2.89

12.67

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

214

2.89

12.67

1.3

—

(3042517) Benzodiazepines panel - Urine

11.93

12.65

5.9

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

137

710

2.04

12.64

3.8

3.4

mmol/l

1.2

1.7

0.56

529

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

340

2.44

11.96

1.3

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

406

2920

1.57

11.88

1.8

1.7

mmol/l

2.0

1.5

2.52

354

2457

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

4.80

11.68

1.4

1.6

iu/ml

—

1679021.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

257

1660

1.68

11.64

2.1

1.8

—

(3019060) Gas panel - Arterial blood

143

777

1.94

11.52

10.2

4.9

—

(3020630) Protein [Mass/volume] in Serum or Plasma

153

856

1.89

11.29

2.2

2.7

g/l

66.4

0.01

133

795

(3023487) Leukocytes [#/volume] in Peritoneal fluid

5.18

11.28

1.4

2.4

e6/l

1315.4

1051.7

0.12

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

350

2.37

11.23

3.2

1.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

173

1017

1.81

10.89

2.7

2.4

ug/l

4.8

8.7

3.69

154

932

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

331

2.38

10.78

2.3

2.8

g/l

0.4

1.3

2.05

302

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

359

2.31

10.61

2.1

2.6

g/l

3.1

0.09

292

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

298

2.43

10.45

2.7

2.8

g/l

0.1

0.0

0.19

280

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

326

2287

1.57

10.43

1.8

mg/l

1.4

1.2

0.37

251

1775

(3008116) Ketones [Moles/volume] in Urine by Test strip

8.74

10.24

2.1

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

362

2.26

9.98

2.4

2.3

77.1

90.1

3.44

347

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

334

2.29

9.70

3.4

3.0

mg/l

1.9

1.5

2.31

312

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

381

2.20

9.62

2.2

1.8

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

356

2.24

9.54

2.2

2.6

g/l

10.4

10.3

0.07

311

(3016650) Hepatitis A virus Ab [Presence] in Serum

195

2.68

9.51

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

122

670

1.91

9.51

1.8

1.7

g/l

1.1

1.4

1.58

111

626

(3026493) Urate [Moles/volume] in Serum or Plasma

413

3099

1.49

9.50

2.8

2.7

umol/l

378.2

5396.8

8.31

359

2736

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

280

2.39

9.47

2.4

2.8

g/l

0.0

0.00

262

(3028271) Lactate [Moles/volume] in Capillary blood

179

2.75

9.39

2.4

2.2

mmol/l

1.8

1.6

0.38

172

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

5.20

9.37

1.4

2.0

e6/l

2449.5

2984.9

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

381

2.17

9.22

2.1

2.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

381

2.17

9.22

2.1

2.5

g/l

4.1

3.9

0.70

287

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

381

2.17

9.22

2.2

2.5

g/l

7.5

7.2

0.57

299

(3036489) Thrombin time

415

2.12

9.20

1.8

2.2

23.5

22.3

0.48

373

(36660697) Celiac disease serology panel - Serum

123

685

1.88

9.19

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

278

2.37

9.16

2.4

2.8

g/l

0.0

0.00

262

(3021589) Normoblasts [#/volume] in Blood

583

4696

1.43

9.16

14.2

9.7

e9/l

0.0

0.07

482

3864

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

310

2.29

9.15

2.3

2.7

g/l

36.6

37.8

0.65

273

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

4.52

8.85

3.3

2.8

—

(3020891) Body temperature

474

2.01

8.63

8.0

4.9

—

(3022313) Gas panel - Capillary blood

100

538

1.93

8.30

4.0

3.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

474

1.99

8.29

2.3

2.1

ug/l

4.6

2.2

0.71

430

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

272

2.30

8.26

1.2

1.3

—

(3044007) Cell count panel - Peritoneal fluid

5.05

8.15

1.6

2.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

414

2.05

8.14

2.4

2.0

—

(40767503) Oxygen content in Capillary blood by calculation

243

2.36

8.07

3.2

2.7

15.1

16.8

1.70

131

(3036481) Cortisol [Moles/volume] in Serum or Plasma

150

930

1.69

7.79

2.2

2.3

nmol/l

337.4

364.6

1.07

135

874

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

473

1.95

7.67

4.2

3.7

mmol/l

24.7

24.8

0.14

449

(3013707) Erythrocyte sedimentation rate by Westergren method

867

7640

1.40

7.38

4.2

3.9

mm/h

16.6

11.0

14.78

795

7101

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

224

2.33

7.18

1.4

1.2

—

(21494755) Public health laboratory ask at order entry panel

1272

0.51

6.98

1.3

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

197

1341

1.55

6.98

1.2

1.3

titre

272.0

410.7

1.41

259

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

4.40

6.97

1.5

2.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

336

2.05

6.81

3.3

3.6

mg/l

38.1

52.0

0.39

267

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

223

2.29

6.81

1.4

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

130

806

1.68

6.75

1.6

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

336

2.02

6.46

3.3

3.6

mg/l

55.2

78.6

0.56

264

(3047181) Lactate [Moles/volume] in Blood

373

1.96

6.36

13.2

6.2

mmol/l

1.7

1.3

1.65

323

(3000494) Fungus identified in Specimen by Culture

190

1314

1.52

6.24

1.8

1.5

—

(3037756) Immunofixation for Serum or Plasma

213

2.25

6.19

1.4

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

121

2.69

6.18

1.1

1.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

189

2.32

6.08

1.1

g/l

1.7

1.5

1.67

172

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

279

2096

1.42

5.99

2.0

1.6

pmol/l

432.9

37647472.9

2.15

218

1785

(3026692) Albumin [Mass/volume] in Peritoneal fluid

4.55

5.99

1.1

1.4

g/l

8.1

12.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1150

0.53

5.98

2.0

1.9

—

(3008295) Osmolality of Serum or Plasma

106

2.78

5.98

1.2

mosm/kgh2o

277.4

284.6

0.82

(3035350) Ketones [Presence] in Urine by Test strip

586

4959

1.33

5.90

3.8

3.2

estimate

0.0

0.00

119

939

(3006653) Thiamine [Moles/volume] in Blood

3.23

5.88

1.0

1.2

nmol/l

148.4

145.3

0.09

(3015235) Bicarbonate [Moles/volume] in Capillary blood

293

2.02

5.82

3.3

2.8

mmol/l

23.4

24.9

1.61

256

(3002331) Protein [Mass/volume] in Peritoneal fluid

5.04

5.75

1.1

1.5

g/l

6.6

26.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

243

2.10

5.57

3.3

3.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

11.32

5.29

1.2

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

170

2.27

5.20

6.0

6.8

mg/l

11.7

10.9

0.60

157

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

103

2.66

5.17

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

321

1.91

5.15

1.6

1.7

—

(40761536) Microorganisms panel - Urine sediment

129

858

1.56

5.06

4.9

3.7

—

(3034988) Calcium [Moles/volume] in Capillary blood

4.81

5.02

1.7

2.1

mmol/l

1.1

1.2

0.50

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

120

788

1.58

4.98

6.2

4.4

mmol/l

1.2

2.82

105

697

(3009261) Glucose [Presence] in Urine by Test strip

581

4994

1.29

4.93

3.8

3.2

estimate

0.0

0.50

116

898

(3021601) Nitrite [Presence] in Urine by Test strip

574

4936

1.29

4.82

5.0

4.3

estimate

0.0

0.50

129

967

(3019225) pH of Specimen

140

960

1.51

4.79

5.0

4.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1131

10677

1.43

4.73

34.8

14.2

mg/l

43.1

25.8

28.11

1043

8450

(3008152) Bicarbonate [Moles/volume] in Arterial blood

115

761

1.56

4.63

16.0

7.1

mmol/l

24.5

24.6

0.03

109

708

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

174

2.16

4.53

3.1

3.0

u/ml

1041.7

144.0

0.40

165

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

747

0.51

4.34

1.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

128

881

1.50

4.31

2.9

2.6

ml/min/173m2

73.8

68.9

0.42

325

(3010813) Leukocytes [#/volume] in Blood

1163

12060

0.69

4.26

45.7

20.5

e9/l

7.8

6.7

40.93

1136

11744

(3024891) Influenza virus A+B Ag [Presence] in Specimen

284

1.87

4.24

1.2

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

1163

12058

0.69

4.22

46.2

20.6

g/l

130.7

140.5

66.66

1149

11898

(3026361) Erythrocytes [#/volume] in Blood

1163

12057

0.69

4.20

45.7

20.5

e12/l

4.3

4.6

75.57

1134

11741

(3017509) Phencyclidine [Presence] in Urine

6.96

4.16

1.9

1.4

—

(3024731) MCV [Entitic volume]

1163

12055

0.69

4.16

45.6

20.4

92.2

91.0

13.64

1151

11900

(3035941) MCH [Entitic mass]

1163

12055

0.69

4.16

45.5

20.4

30.9

30.5

7.54

1151

11899

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

4.37

4.09

3.1

2.5

—

(4281824)

2.88

4.07

1.3

1.2

—

(3007461) Platelets [#/volume] in Blood

1163

12049

0.69

4.04

45.8

20.5

e9/l

248.3

240.4

2.98

1142

11761

(3019832) Treponema pallidum Ab [Presence] in Serum

590

1.58

4.02

1.8

1.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

803

7293

1.26

3.98

3.5

3.3

pmol/l

14.5

14.8

1.80

710

6637

(3019550) Sodium [Moles/volume] in Serum or Plasma

1163

11098

1.42

3.98

39.9

16.4

mmol/l

138.1

139.7

60.24

1145

10853

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

451

5216

0.79

3.80

3.9

20.9

21.4

0.25

177

2365

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

2.42

3.74

1.0

1.2

u/l

63.6

57.6

0.19

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

122

2.24

3.68

3.5

4.9

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

2.56

3.64

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

199

1.94

3.56

1.2

2.0

—

(3019977) pH of Arterial blood

2.72

3.49

4.5

3.6

7.4

—

(4146454)

120

2.19

3.39

3.1

2.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

239

1.83

3.38

2.6

2.3

g/l

125.0

133.6

1.37

173

(4010399)

108

757

1.46

3.37

1.4

—

(40768446) Kidney Pathology biopsy report

2.85

3.36

1.8

—

(3013512) EKG study

366

3085

1.26

3.36

4.7

3.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1162

11144

1.37

3.32

40.0

16.6

mmol/l

4.0

8.20

1144

10891

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

480

1.57

3.31

2.0

2.3

—

(3045788) Cell count panel - Pleural fluid

102

2.28

3.30

1.4

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

417

1.61

3.29

2.1

2.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

249

1.79

3.27

1.2

1.6

—

(3021901) Oxygen saturation in Capillary blood

214

1.85

3.20

3.5

2.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.97

3.14

1.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

118

2.14

3.11

1.4

e6/l

11659.8

67335.8

—

(3023199) Leukocytes [#/volume] in Pleural fluid

132

2.07

3.08

1.4

1.5

e6/l

1842.7

1649.5

0.14

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

249

1.75

2.99

4.4

6.8

iu/ml

661.0

602.9

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

272

1.72

2.97

1.2

1.9

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

220

1.80

2.96

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

111

803

1.42

2.95

1.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.16

2.93

1.2

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

281

1.70

2.92

1.2

1.9

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

128

2.05

2.92

1.2

2.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.27

2.87

1.1

1.9

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

5.41

2.87

1.6

2.3

ng/l

98.3

112.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

504

0.53

2.85

1.3

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

268

1.70

2.85

1.4

1.6

—

(3012441) Differential panel - Pleural fluid

116

2.09

2.84

1.3

1.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

979

9238

1.24

2.81

4.7

4.0

mu/l

1.9

2.1

0.70

885

8457

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

132

1.99

2.71

2.0

2.2

32.0

33.4

0.56

132

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

331

3841

0.82

2.64

2.9

2.8

ug/l

0.6

0.7

2.83

220

2405

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

113

2.05

2.62

2.6

u/l

9.9

3305.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

299

1.63

2.59

2.0

2.5

ug/min

253.0

146.5

0.30

179

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

4.02

2.57

1.4

1.2

—

(3025941) Bacteria identified in Stool by Culture

560

1.46

2.57

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

119

896

1.36

2.53

1.9

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

294

1.62

2.50

1.3

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

295

1.62

2.47

1.3

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

4.39

2.47

1.0

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

188

1.77

2.46

2.1

3.2

—

2907.6

—

(3021788) Differential panel - Synovial fluid

188

1.77

2.46

1.2

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

116

2.00

2.46

2.4

2.2

mg/l

10.2

20.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.83

2.46

1.0

1.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

3.83

2.46

2.0

2.1

mmol/l

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

345

2977

1.22

2.46

3.0

3.1

ng/l

2084.5

1306.5

1.48

293

2535

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

166

1.83

2.46

1.2

1.8

—

(3003434) Protein [Mass/volume] in Pleural fluid

152

1.86

2.44

1.4

1.5

g/l

29.7

32.1

0.38

134

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

242

1.67

2.43

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

297

1.60

2.41

1.3

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.96

2.41

3.7

3.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.96

2.41

3.7

3.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1051

10925

0.81

2.38

4.9

4.5

mmol/l

4.3

4.6

11.01

968

10242

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1045

10867

0.81

2.36

4.9

4.4

mmol/l

1.3

6.93

951

10123

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

245

1.65

2.33

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

892

0.68

2.32

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

333

1.55

2.30

1.3

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.49

2.27

1.4

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.90

2.25

6.4

5.6

mmol/l

7.1

6.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

142

1.85

2.24

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

143

1.83

2.20

1.2

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.35

2.18

1.0

1.6

—

(3044889) 12 lead EKG panel

822

7708

1.18

2.17

4.4

3.8

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1069

10262

1.23

2.17

29.6

13.0

ml/min/173m2

87.4

82.9

7.28

929

8564

(3003694) ABO and Rh group [Type] in Blood

334

2906

1.20

2.16

1.4

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

115

1.93

2.16

1.1

2.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.31

2.15

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.38

2.12

1.1

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

205

1.68

2.12

1.1

1.7

—

(3023410) Appearance of Cerebral spinal fluid

102

1.98

2.11

1.3

—

(3000012) Reticulocyte production index

2.57

2.10

1.6

1.7

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1059

10168

1.22

2.08

8.7

5.7

mmol/mol

46.3

40.2

21.63

993

9523

(3004716) Salmonella sp identified in Stool by Organism specific culture

452

1.44

2.01

1.4

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

110

854

1.31

1.95

2.9

2.8

ng/l

276.0

185.9

0.95

100

768

(3019150) Specific gravity of Urine by Refractometry

255

2184

1.21

1.95

4.0

3.4

kg/l

1.0

1.20

292

(3000492) Spirometry study

146

1177

1.27

1.94

1.5

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

4.56

1.94

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

4.56

1.94

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

299

1.52

1.92

1.9

2.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

106

1.90

1.91

2.8

2.6

—

(3020874) Milk IgE Ab [Units/volume] in Serum

0.00

1.89

0.0

1.1

—

1.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

229

1.59

1.86

1.4

1.2

u/ml

332.6

286.2

0.35

142

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

167

1.69

1.85

1.1

1.7

—

(3002385) Erythrocyte distribution width [Ratio]

927

8836

1.17

1.80

38.5

17.2

14.0

13.6

14.49

914

8663

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

3.05

1.80

3.0

1.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

2.35

1.78

1.2

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

170

1.66

1.74

4.6

4.2

—

(3002256) Pathology report gross observation

156

1286

1.24

1.73

1.2

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

305

2683

1.18

1.72

4.8

3.5

estimate

0.0

0.15

107

910

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

250

1.54

1.72

1.5

1.4

—

16.9

—

(3050794) Legionella sp Ab [Presence] in Serum

3.86

1.71

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

111

1.81

1.69

1.0

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

126

1.76

1.68

3.3

7.0

mmol/l

7.6

7.2

0.23

105

(3002619) Bacteria identified in Specimen by Culture

3.17

1.66

1.0

1.2

—

(3018572) Chloride [Moles/volume] in Blood

277

1.50

1.65

20.4

6.7

mmol/l

103.1

105.5

1.64

246

(3039000) Anion gap in Blood

277

1.50

1.65

20.3

6.7

mmol/l

11.4

11.5

0.04

246

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.90

1.65

1.9

1.7

—

76.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

471

1.38

1.64

14.2

5.3

0.9

0.16

439

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

105

1.82

1.63

1.2

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

447

0.64

1.59

1.4

1.6

—

(40768804) Tissue Pathology biopsy report

430

3909

1.15

1.57

2.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1079

11100

0.84

1.57

5.6

4.9

mmol/l

2.4

2.8

25.67

989

10344

(3020876) Protein [Mass/time] in 24 hour Urine

1.86

1.56

1.7

2.2

—

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.12

1.55

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.28

1.53

1.5

1.0

miu/ml

1535.5

1291.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.34

1.52

1.0

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

3.34

1.52

1.0

mg/g

11.4

9.7

—

(40765096) Chromosome analysis panel by Banding

0.00

1.52

0.0

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

125

0.40

1.50

7.2

2.6

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

551

1.32

1.47

1.9

2.9

e6/l

0.2

0.08

539

(3008757) Leukocyte morphology finding [Identifier] in Blood

125

1.69

1.44

1.8

4.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.13

1.44

1.0

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

2.04

1.43

1.3

1.1

—

(3037121) Protein [Mass/volume] in Urine

388

1.38

1.43

3.5

3.6

g/l

0.6

0.3

0.93

186

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

477

1.34

1.39

14.9

5.3

2.2

1.7

1.08

445

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

399

1.37

1.39

1.5

1.6

—

561.5

—

(3035880) pH of Pleural fluid

1.95

1.38

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

159

1.58

1.35

2.5

2.9

nmol/l

0.7

0.9

1.12

122

(3021387) Prolactin [Units/volume] in Serum or Plasma

299

1.42

1.34

1.2

1.6

mu/l

224.1

286.3

1.74

282

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.88

1.34

1.1

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.88

1.34

1.4

1.6

—

(3022145) Colonoscopy Study observation

145

1222

1.21

1.34

1.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

1.34

0.0

3.6

—

95.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

1.34

0.0

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

258

0.58

1.32

1.5

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

178

1.53

1.26

1.1

1.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

347

1.37

1.24

1.3

1.4

u/l

7.0

5.8

0.31

280

(3004809) Band form neutrophils/100 leukocytes in Blood

163

1.54

1.23

1.9

3.9

0.6

1.3

1.15

140

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

229

1.45

1.22

1.6

1.5

u/ml

114.4

122.5

—

(3014271) Vancomycin [Susceptibility]

2.05

1.22

2.4

2.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

246

1.43

1.22

1.8

2.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.64

1.21

1.8

1.1

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

213

1.47

1.21

3.4

3.3

e9/l

4.9

4.2

0.79

213

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

223

1.45

1.17

3.4

3.6

59.5

56.8

0.71

223

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

1.16

0.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

1.16

0.0

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

110

1.65

1.15

1.2

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

110

1.65

1.15

1.2

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

110

1.65

1.15

1.2

1.8

—

(3017181) Myelocytes/100 leukocytes in Blood

106

881

1.22

1.15

2.3

4.6

0.8

0.9

0.29

271

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

1.14

0.0

2.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

1.14

0.0

5.7

—

(3048689) Calprotectin [Mass/mass] in Stool

135

1151

1.19

1.13

2.0

2.5

ug/g

156.4

158.0

0.01

113

954

(3017446) Testosterone [Moles/volume] in Serum or Plasma

178

1554

1.17

1.13

2.2

2.4

nmol/l

13.3

13.6

0.24

146

1396

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.01

1.12

1.0

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

311

1.36

1.11

1.1

1.3

g/l

0.2

0.16

296

(3044941) Cell count panel - Synovial fluid

176

1.49

1.10

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

160

1.51

1.09

1.1

1.6

—

(3016018) Differential panel - Cerebral spinal fluid

112

1.62

1.09

1.2

—

(3017569) Oxygen content in Arterial blood

1.83

1.09

3.9

3.1

—

(40761535) Cells panel - Urine sediment

105

879

1.21

1.08

3.8

3.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.76

1.07

1.4

1.8

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

1.66

1.07

2.0

4.3

62.1

55.3

0.55

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.80

1.05

1.0

1.9

—

(3009542) Hematocrit [Volume Fraction] of Blood

1025

9972

1.13

1.04

35.2

14.8

38.8

41.3

18.10

705

7412

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.28

1.03

1.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.28

1.03

1.0

1.8

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

150

0.53

1.03

1.1

—

4.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1027

10529

0.89

1.02

4.5

4.0

mmol/l

1.7

1.4

3.98

944

9780

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

151

1315

1.17

1.01

11.9

7.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

181

1.45

0.98

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.84

0.98

1.4

1.2

—

(3038515) Glucose [Moles/volume] in Venous blood

212

0.61

0.98

4.8

3.1

mmol/l

9.0

7.5

0.78

206

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.81

0.96

2.4

2.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

225

1.39

0.95

1.2

1.4

iu/l

14.7

21.7

0.93

184

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.77

0.94

3.0

1.6

—

(1002224) Polysomnography panel

576

0.77

0.93

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

167

1.45

0.92

1.2

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

184

1.42

0.92

2.2

2.6

—

3.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.15

0.91

1.0

3.5

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

210

1.39

0.91

1.2

—

397.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.91

0.88

1.0

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

253

0.67

0.88

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

264

1.33

0.86

1.4

1.6

e6/l

15766.7

15535.4

0.01

193

(4094501)

356

0.72

0.86

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.72

0.86

3.2

2.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

433

1.26

0.86

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

104

1.55

0.84

1.2

1.3

—

36.0

—

(3044290) Cell count panel - Cerebral spinal fluid

222

1.36

0.84

1.2

1.3

—

(3042733) HLA Ab [Presence] in Serum

1.76

0.83

4.3

5.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

830

1.18

0.83

2.4

4.7

0.1

0.67

245

(3025130) Human papilloma virus identified in Specimen

1.74

0.82

2.1

1.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

1.55

0.81

1.1

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.71

0.80

1.0

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

321

1.29

0.80

1.1

1.3

g/l

1.3

1.2

1.16

306

(3017732) Neutrophils [#/volume] in Blood

695

1.19

0.79

3.8

3.3

e9/l

4.9

4.2

1.62

556

(3035320) C reactive protein [Mass/volume] in Body fluid

1.67

0.78

2.4

2.0

—

(40768441) Liver Pathology biopsy report

1.63

0.78

2.3

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

226

1.34

0.76

1.4

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.70

0.76

1.6

1.2

—

(3047189) Immunofixation for 24 hour Urine

1.70

0.76

1.1

1.9

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.65

0.75

1.0

1.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

150

1.41

0.73

1.0

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.64

0.73

1.1

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

219

0.68

0.73

2.2

3.7

mg/l

18.7

27.1

—

136

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

242

0.70

0.73

1.0

1.2

—

2.9

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.61

0.72

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

686

6606

1.08

0.72

3.1

2.7

—

(3002179) Metamyelocytes/100 leukocytes in Blood

805

1.17

0.71

2.3

4.4

0.5

0.01

200

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

126

1.43

0.70

1.1

1.5

—

(44790049)

135

1.41

0.69

1.3

1.6

—

(44806118)

135

1.41

0.69

1.3

1.6

—

(44790048)

135

1.41

0.69

1.3

1.6

—

(44790047)

135

1.41

0.69

1.3

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

227

0.70

0.68

3.4

4.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.63

0.67

1.3

1.2

—

(3022689) Creatine [Moles/volume] in Urine

1.79

0.66

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

128

1.41

0.66

1.1

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

128

1.41

0.66

1.1

1.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

143

1287

1.12

0.65

4.9

4.4

30.7

30.6

0.03

110

896

(3022621) pH of Urine by Test strip

590

1.18

0.63

2.2

2.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

165

1502

1.11

0.62

1.5

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

182

1.32

0.61

1.2

u/ml

1.6

3.5

—

(4306422)

183

1.32

0.59

1.3

1.2

—

(3024932) HLA-DR beta [Type]

1.54

0.59

1.0

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.59

0.0

1.0

—

44.8

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

246

1.27

0.58

1.2

1.3

e6/l

13.3

42.5

0.60

192

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

246

1.27

0.58

1.2

1.4

e6/l

10.0

910.8

1.05

199

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

179

1643

1.10

0.58

1.3

iu/ml

34.5

34.1

0.01

513

(3024471) HLA-A [Type]

1.51

0.58

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.58

0.0

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

0.00

0.58

0.0

1.8

—

138.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

175

1.32

0.58

1.2

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.46

0.56

1.1

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.46

0.56

1.1

1.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.46

0.56

1.1

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

125

0.64

0.54

1.4

1.3

—

(3016750) Collection duration of Urine

1.47

0.54

1.6

2.3

min

461.2

502.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

1.47

0.54

1.0

1.4

mmol/l

2.0

0.13

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.58

0.54

1.0

2.4

ug/l

2.5

1.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

488

1.18

0.54

1.4

2.0

u/l

41.9

39.4

0.37

435

(3024263) Appearance of Synovial fluid

1.45

0.53

1.4

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.43

0.53

1.2

—

(21494434) Karyotype in Bone marrow

100

0.60

0.51

1.0

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.50

0.51

1.0

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

135

1.34

0.51

1.3

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

629

6488

0.94

0.51

4.1

4.4

ug/l

1.9

2.3

0.91

545

5902

(40768806) Pleura Pathology biopsy report

118

1.36

0.50

1.4

1.6

—

(3028433) Virus identified in Specimen by Culture

1.47

0.50

1.2

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

127

1.34

0.49

1.2

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

244

1.23

0.48

1.1

1.3

miu/ml

225.8

216.6

—

101

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.40

0.48

2.7

1.5

g/l

1.0

0.12

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.45

0.48

1.0

1.8

—

(3044927) Protein electrophoresis panel - Urine

102

1.38

0.47

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

199

0.75

0.46

1.0

1.2

—

1.5

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1149

11610

0.92

0.46

36.6

16.5

umol/l

81.3

83.0

0.75

1149

11605

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.40

0.45

1.0

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.40

0.45

1.1

1.6

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

1.37

0.44

1.0

1.3

—

1.9

—

(40768443) Skin Pathology biopsy report

433

1.16

0.43

1.1

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

247

2335

1.07

0.43

3.6

4.8

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.62

0.43

1.0

1.2

—

(3003338) MCHC [Mass/volume]

911

9268

0.94

0.42

40.2

17.7

g/l

333.6

334.5

2.14

905

9217

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.64

0.42

21.7

16.0

nmol/l

1135.5

1413.0

—

(44806420)

1.52

0.41

1.8

2.5

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

0.00

0.41

0.0

1.3

—

0.6

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

105

1.34

0.41

1.5

1.9

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

352

1.17

0.40

1.1

1.2

—

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

123

1.30

0.40

1.3

2.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

123

1.30

0.40

1.0

1.5

64.9

61.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.47

0.40

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.34

0.40

1.1

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1.37

0.40

1.3

1.4

—

(40768795) Lymph node Pathology biopsy report

103

0.68

0.39

1.1

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

196

1.23

0.39

2.6

1.8

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

115

1.31

0.39

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

124

1.29

0.38

1.1

—

(3023419) Bacteria identified in Sputum by Culture

160

1.25

0.38

3.0

2.6

—

(4027681)

1.37

0.38

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

136

0.73

0.37

1.2

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.35

0.37

9.6

6.7

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.35

0.37

1.2

1.3

ug/l

11.8

9.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

407

0.86

0.37

1.3

1.8

mg/l

10.2

4.6

0.54

289

(4024509)

1.29

0.36

1.7

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

123

0.73

0.35

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

126

1.27

0.35

2.3

2.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1060

10479

1.06

0.35

5.7

4.5

mmol/l

7.0

6.1

26.65

961

9647

(3008037) Lactate [Moles/volume] in Venous blood

222

0.81

0.34

3.8

3.1

mmol/l

2.1

1.5

0.56

214

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

181

1.22

0.34

1.2

u/ml

5.4

5.3

—

(3051593) INR in Capillary blood by Coagulation assay

1.37

0.34

1.0

15.9

—

(3025159) Blasts/100 leukocytes in Blood

778

1.10

0.34

2.5

4.8

0.0

0.1

1.57

212

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

474

1.12

0.32

2.4

3.5

pmol/l

4.4

4.6

0.61

428

(3000330) Specific gravity of Urine by Test strip

442

0.88

0.31

3.5

3.2

—

(4035726)

880

1.09

0.30

1.5

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

120

1.25

0.30

1.1

1.4

—

(3045424) Erythrocytes [Presence] in Urine

184

0.81

0.28

1.6

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

121

1.24

0.28

1.4

1.1

—

(40768800) Prostate Pathology biopsy report

375

0.88

0.28

1.3

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.27

0.27

1.4

2.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.27

0.27

1.4

2.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.27

0.27

1.4

2.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.27

0.27

1.4

2.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

299

1.14

0.27

1.3

1.4

—

(3025577) Chromium [Mass/volume] in Blood

0.70

0.26

2.4

2.0

ug/l

3.1

1.9

—

(3026470) Cobalt [Mass/volume] in Blood

0.69

0.26

2.4

2.0

ug/l

5.3

3.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

618

1.09

0.25

1.2

1.3

—

(3004775) Volume in Urine collected for unspecified duration

105

1.24

0.25

1.6

2.3

873.7

655.9

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

137

0.80

0.24

1.7

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

133

1.21

0.24

1.3

2.1

—

(4034850)

349

0.89

0.24

8.6

9.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

161

1538

1.05

0.23

1.2

u/ml

1.7

10.6

6.52

630

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

316

0.88

0.22

1.3

1.8

—

(3034426) Prothrombin time (PT)

1.25

0.22

1.4

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

219

1.14

0.22

1.2

1.4

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.21

0.0

11.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3019174) dRVVT (LA screen)

0.00

0.21

0.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.21

0.0

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

0.21

0.0

2.7

—

0.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

101

0.79

0.21

1.1

1.3

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

25.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.21

0.0

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.20

0.0

2.4

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

9.3

—

0.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.25

0.20

1.2

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.25

0.20

1.2

1.5

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.23

0.20

1.5

1.3

ug/l

11.2

6.9

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.23

0.20

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

114

0.79

0.20

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

127

1.18

0.19

1.0

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.18

0.19

5.7

7.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.18

0.19

2.5

4.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

184

1.14

0.19

1.0

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

109

1.19

0.18

1.0

1.3

25.7

26.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

128

1.17

0.18

1.0

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

128

1.17

0.18

1.0

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.17

0.17

1.1

2.9

—

(3017704) Immunofixation for Urine

0.75

0.17

1.2

1.4

—

(3036603) Volume of Urine

1.16

0.16

1.5

—

1708.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

182

0.88

0.15

2.4

1.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

140

1.14

0.15

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

492

0.93

0.15

1.0

1.2

iu/ml

78.8

156.2

1.08

181

(4268621)

129

0.85

0.14

2.5

2.4

—

(3045142) Bone marrow Pathology biopsy report

129

0.85

0.14

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

0.81

0.14

2.4

3.1

—

39.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.81

0.14

1.0

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

112

1.16

0.14

1.2

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

170

0.88

0.13

1.1

1.4

pmol/l

92.6

228.4

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

132

1.14

0.13

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

138

0.87

0.13

1.5

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

271

2765

0.97

0.13

3.7

3.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

392

0.94

0.10

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

575

0.95

0.10

1.3

1.4

—

(3008898) HLA-B27 [Presence]

360

0.94

0.09

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

184

1.09

0.09

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

1.07

0.08

2.7

2.4

umol/l

73.5

53.2

—

(44813793)

1.03

0.08

1.0

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

1.03

0.08

1.0

2.5

u/l

148.2

199.9

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.81

0.08

1.0

1.3

—

(3004451) EKG impression Narrative

1.05

0.08

1.7

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.82

0.07

1.2

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

286

0.94

0.07

1.6

1.7

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

0.85

0.07

1.0

1.2

—

94.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

255

0.94

0.07

1.0

1.2

—

10.8

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

183

0.93

0.06

1.0

1.1

—

33.6

—

(40761511) CBC panel - Blood by Automated count

1126

11234

1.02

0.06

29.6

13.2

—

(3049717) Cytology report of Urine Cyto stain

488

1.03

0.03

2.1

2.8

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

113

1145

0.99

0.03

1.6

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

192

1.04

0.02

1.1

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

399

0.98

0.02

1.1

—

82.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1159

11601

0.99

0.02

21.1

10.4

u/l

33.1

30.5

3.20

1128

11265

(3005570) Glucose [Moles/volume] in Urine

103

1.07

0.02

1.6

1.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

611

1.02

0.02

1.2

1.3

u/ml

457.6

274.1

0.95

563

(3042631) Mycobacterium sp identified in Specimen

167

0.96

0.01

1.9

2.9

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

134

1.05

0.00

1.0

1.1

u/ml

2.9

2.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

102

0.98

0.00

1.4

1.5

—

(3045414) Leukocytes [Presence] in Urine

418

1.00

0.00

2.3

1.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

390

3896

1.00

0.00

4.4

3.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.96

0.00

1.4

2.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(21494815) CD4 cells/100 lymphocytes in Specimen

0.92

0.00

2.2

2.3

—

40.7

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.85

0.00

1.0

1.2

iu/ml

119.4

212.9

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.99

0.00

1.0

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.1

—

403.3

—

(3001729) Color of Synovial fluid

0.00

0.0

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

11.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.98

0.00

1.4

2.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.0

2.9

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.88

0.00

1.3

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.99

0.00

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.95

0.00

1.0

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

3.8

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

2.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.1

—

(4038314)

0.00

0.0

1.3

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

7.3

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.5

—

2.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.95

0.00

1.0

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.95

0.00

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.92

0.00

1.1

1.3

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.98

0.00

1.4

2.4

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.0

1.2

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.0

2.0

—

(3044336) Cobalt [Moles/volume] in Urine

0.00

0.0

1.8

—

14.2

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.0

2.1

—

0.8

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

2.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

0.0

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.0

1.5

—

(40768793) Breast Pathology biopsy report

0.95

0.00

1.0

1.3

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

2.0

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

0.0

1.0

—

0.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

0.00

0.0

1.5

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

4.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.99

0.00

1.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.8

—

(3011048) Pyruvate [Moles/volume] in Blood

0.00

0.0

1.2

—

70.5

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.0

1.6

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.4

—

831.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

2.0

—

2.0

—

(3013762) Body weight Measured

0.00

0.0

1.4

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.0

2.6

—

(4212803)

0.00

0.0

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.01

0.00

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint ALCOPANCACU and mortality.

Females

Parameter	HR [95% CI]	p-value
ALCOPANCACU	4.5 [2.55, 7.94]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.196

During the follow-up period (1.1.1998 — 31.12.2019), 91 out of 815 females with ALCOPANCACU died.

Males

Parameter	HR [95% CI]	p-value
ALCOPANCACU	3.965 [3.18, 4.95]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.007

During the follow-up period (1.1.1998 — 31.12.2019), 456 out of 3511 males with ALCOPANCACU died.

Mortality risk

Mortality risk for people of age

years, who have ALCOPANCACU.

N-year risk	Females	Males
1	0.291%	0.681%
5	3.029%	4.904%
10	6.421%	12.006%
15	12.055%	21.085%
20	20.524%	33.046%

Relationships between endpoints

↥

Index endpoint: ALCOPANCACU – Alcohol-induced acute pancreatitis

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Alcohol-induced acute pancreatitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints